Gut Microbiota and Non-Alcoholic Fatty Liver Disease: New Insights

Clinical Microbiology and Infection - United Kingdom
doi 10.1111/1469-0691.12140
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Phenotyping Non-Alcoholic Fatty Liver Disease by the Gut Microbiota - Ready for Prime Time?

Journal of Gastroenterology and Hepatology
HepatologyGastroenterology
2020English

Non-Alcoholic Fatty Liver Disease and Disease Mongering

American Journal of Medicine
Medicine
2019English

Review Article: New Treatments in Non-Alcoholic Fatty Liver Disease

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Global Perspectives on Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis

Hepatology
MedicineHepatology
2019English

Endotoxemia by Porphyromonas Gingivalis Injection Aggravates Non-Alcoholic Fatty Liver Disease, Disrupts Glucose/Lipid Metabolism, and Alters Gut Microbiota in Mice

Frontiers in Microbiology
Microbiology
2018English

Treatment of Non-Alcoholic Fatty Liver Disease

Postgraduate Medical Journal
Medicine
2006English

Headway and Hurdles in Non-Alcoholic Fatty Liver Disease

Lancet Gastroenterology and Hepatology, The
HepatologyGastroenterology
2020English

Diagnosis and Characterization of Non-Alcoholic Fatty Liver Disease

2018English

Emerging New Standard for Non-Invasive Assessment of Liver Disease Mortality in Non-Alcoholic Fatty Liver Disease

HepatoBiliary Surgery and Nutrition
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy